申请人:Giblin Gerard Martin Paul
公开号:US20100273853A1
公开(公告)日:2010-10-28
A compound of formula (1) or a pharmaceutically acceptable derivative thereof,
where R
1
, R
2
, R
3
, R
4
, R
5
, X and Y are as defined in the specification; corresponding processes for preparing; pharmaceutical compositions comprising; and medicinal uses of such compounds.
一个化学式为(1)的化合物或其药学上可接受的衍生物,其中R1,R2,R3,R4,R5,X和Y的定义如规范所述;相应的制备过程;包括制药组合物;以及这些化合物的药用用途。